An astonishing new study has emerged, revealing that the Covid mRNA vaccines may have caused an unprecedented ... questions into the forefront of public discourse regarding vaccine safety. Claims ...
Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.
Dr Patrick Moore, the study's chief investigator and the National Institute for Health and Care Research (NIHR) director in ...
Deep-pocketed investors have adopted a bearish approach towards Capricor Therapeutics CAPR, and it's something market players ...
Participants, about 80% of whom had a previous COVID-19 infection, received a median of four COVID-19 vaccine doses. “In this ...
During the COVID pandemic, many of us received multiple mRNA vaccines. New work by researchers at the VIB-UGent Center for ...
During the COVID pandemic, many of us have received multiple mRNA vaccines. New work by researchers at the VIB-UGent Center ...
The FDA approves Pfizer's RSV vaccine, Abrysvo, for adults aged 18-59 years with increased risk of the disease.
A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.
The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower ...
A new vaccine against the winter vomiting bug, norovirus, is being tested on volunteers after preliminary findings indicated ...
COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback